Condition: HTLV-I Infections · HTLV-II Infections · Human T-lymphotropic Virus 1 · Sponsor: MP Biomedicals, LLC
This post-market study is intended to assess the performance of the HTLV Blot 2.4 in repository serum/plasma specimens with neurological disorders (n=100) or an HTLV known positive infection (n=50).
This description comes directly from the study's public registry record.
Contact details are listed per location below or on the registry record.
Always discuss trial participation with your own doctor first.
| LABS, Inc. | Philadelphia, Pennsylvania, United States | — |
| Qualtex Laboratories | San Antonio, Texas, United States | — |
| Eastern Virginia Medical School (EVMS) | Norfolk, Virginia, United States | — |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03226119